Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart
Raffaele Altara, Ziad Mallat, George W. Booz, et al.
Journal of Immunology Research (2016) Vol. 2016, pp. 1-12
Open Access | Times Cited: 80

Showing 26-50 of 80 citing articles:

Deciphering immune dynamics in atherosclerosis: Inflammatory mediators as biomarkers and therapeutic target
Paolo Magni, Tijana Mitić, Yvan Devaux, et al.
European Journal of Clinical Investigation (2025)
Closed Access
Circulating exosome long non-coding RNAs are associated with atrial structural remodeling by increasing systemic inflammation in atrial fibrillation patients
Yue Yuan, Xuejie Han, Xinbo Zhao, et al.
Journal of Translational Internal Medicine (2024) Vol. 12, Iss. 1, pp. 106-118
Open Access | Times Cited: 3
Anti-Neuroinflammatory Effects of a Macrocyclic Peptide-Peptoid Hybrid in Lipopolysaccharide-Stimulated BV2 Microglial Cells
Lu Sun, Soraya Wilke Saliba, Matthias Apweiler, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4462-4462
Open Access | Times Cited: 3
Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, in combination with pembrolizumab
Ludimila Cavalcante, Sreenivasa R Chandana, Nehal J. Lakhani, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 8, pp. e009475-e009475
Open Access | Times Cited: 3
Pro-inflammatory effects of the Th1 chemokine CXCL10 in acquired aplastic anaemia
Junhong Li, Meili Ge, Shihong Lu, et al.
Cytokine (2017) Vol. 94, pp. 45-51
Closed Access | Times Cited: 30
Pulmonary fibroblasts-secreted CXCL10 polarizes alveolar macrophages under pro-inflammatory stimuli
Cheng‐Fang Tsai, Jiahong Chen, Wei‐Lan Yeh
Toxicology and Applied Pharmacology (2019) Vol. 380, pp. 114698-114698
Closed Access | Times Cited: 27
Ryanodine receptor and immune‐related molecules in diabetic cardiomyopathy
Chengju Tian, Jinghua Zhang, Jinfeng Liu, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 4, pp. 2637-2646
Open Access | Times Cited: 23
Cell-Target-Specific Anti-Inflammatory Effect of Empagliflozin: In Vitro Evidence in Human Cardiomyocytes
Silvia Giannattasio, Anna Citarella, Sofia Trocchianesi, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 14
A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection
Michael P. Dubé, Ellen S. Chan, Jordan E. Lake, et al.
Clinical Infectious Diseases (2018) Vol. 69, Iss. 7, pp. 1165-1172
Open Access | Times Cited: 27
Immune Checkpoint Inhibitors Mediated Lymphocytic and Giant Cell Myocarditis: Uncovering Etiological Mechanisms
Rishi Rikhi, Jaret M. Karnuta, Muzna Hussain, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 19
Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition
Clarissa Corinaldesi, Rebecca L. Ross, Giuseppina Abignano, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2894-2894
Open Access | Times Cited: 18
Compound Danshen Dripping Pill inhibits doxorubicin or isoproterenol-induced cardiotoxicity
Ke Feng, Yuxin Liu, Jia Sun, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111531-111531
Open Access | Times Cited: 18
Unlocking the Potential of Immunotherapy in Cardiovascular Disease: A Comprehensive Review of Applications and Future Directions
FNU Jyotsna, Jibran Ikram, Fnu Nageeta, et al.
Cureus (2023)
Open Access | Times Cited: 7
Nutritional Support Reduces Circulating Cytokines in Patients with Heart Failure
Aura D. Herrera‐Martínez, Concepción Muñoz Jiménez, A Romo, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1637-1637
Open Access | Times Cited: 2
Genomewide Association Study Identifies Cxcl Family Members as Partial Mediators of LPS-Induced Periodontitis
Sarah Hiyari, Elissa Green, Calvin Pan, et al.
Journal of Bone and Mineral Research (2018) Vol. 33, Iss. 8, pp. 1450-1463
Open Access | Times Cited: 22
Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients
Caroline Perner, Florian Perner, Beatrice Stubendorff, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 22
CXCL9 and CXCL10 display an age-dependent profile in Chagas patients: a cohort study of aging in Bambui, Brazil
Fernanda Fortes de Araújo, Karen Torres, Sérgio Viana Peixoto, et al.
Infectious Diseases of Poverty (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 20
The anti-CXCL4 antibody depletes CD4(+)CD25(+)FOXP3(+) regulatory T cells in CD4+ T cells from chronic osteomyelitis patients by the STAT5 pathway
Kai Huang, Shuyu Ge
Annals of Palliative Medicine (2020) Vol. 9, Iss. 5, pp. 2723-2730
Open Access | Times Cited: 19
The Involvement of CXC Motif Chemokine Ligand 10 (CXCL10) and Its Related Chemokines in the Pathogenesis of Coronary Artery Disease and in the COVID-19 Vaccination: A Narrative Review
Mojgan Noroozi Karimabad, Nicholas G. Kounis, Gholamhossein Hassanshahi, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1224-1224
Open Access | Times Cited: 17
Immune Modulation in Heart Failure: the Promise of Novel Biologics
Paulino Álvarez, Αlexandros Briasoulis
Current Treatment Options in Cardiovascular Medicine (2018) Vol. 20, Iss. 3
Closed Access | Times Cited: 19
T-Cell Subpopulations Exhibit Distinct Recruitment Potential, Immunoregulatory Profile and Functional Characteristics in Chagas versus Idiopathic Dilated Cardiomyopathies
Eula G. A. Neves, Carolina Cattoni Koh, Thaiany Goulart de Souza e Silva, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 10
Effector T cell chemokine IP-10 predicts cardiac recovery and clinical outcomes post-myocardial infarction
Kateryna Sopova, Simon Tual‐Chalot, Matthias Mueller‐Hennessen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
CD4+ CD25+ GARP+ regulatory T cells display a compromised suppressive function in patients with dilated cardiomyopathy
Yuzhen Wei, Kunwu Yu, Hui Wei, et al.
Immunology (2017) Vol. 151, Iss. 3, pp. 291-303
Open Access | Times Cited: 17
Five immune‐gene‐signatures participate in the development and pathogenesis of Kawasaki disease
Han Nie, Shizhi Wang, Quanli Wu, et al.
Immunity Inflammation and Disease (2020) Vol. 9, Iss. 1, pp. 157-166
Open Access | Times Cited: 15
Human cell-based anti-inflammatory effects of rosiglitazone
Mariangela Sottili, Tiziana Filardi, Giulia Cantini, et al.
Journal of Endocrinological Investigation (2021) Vol. 45, Iss. 1, pp. 105-114
Closed Access | Times Cited: 13

Scroll to top